🇺🇸 Vancomycin IV in United States

35 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Alanine Aminotransferase Increased — 6 reports (17.14%)
  2. Aspartate Aminotransferase Increased — 5 reports (14.29%)
  3. Red Man Syndrome — 4 reports (11.43%)
  4. Respiratory Failure — 4 reports (11.43%)
  5. Blood Creatinine Increased — 3 reports (8.57%)
  6. Hypotension — 3 reports (8.57%)
  7. Rash — 3 reports (8.57%)
  8. Renal Failure — 3 reports (8.57%)
  9. Acidosis — 2 reports (5.71%)
  10. Alopecia — 2 reports (5.71%)

Source database →

Other Infectious Disease approved in United States

Frequently asked questions

Is Vancomycin IV approved in United States?

Vancomycin IV does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Vancomycin IV in United States?

Debiopharm International SA is the originator. The local marketing authorisation holder may differ — check the official source linked above.